884(top 1%)
papers
32.3K(top 0.1%)
citations
76(top 0.1%)
h-index
169(top 0.1%)
g-index
941
all documents
35.9K
doc citations
3.7K
citing journals

Top Articles

#TitleJournalYearCitations
1Functions of DNA methylation: islands, start sites, gene bodies and beyondNature Reviews Genetics20124,840
2Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trialLancet, The20173,224
3Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 studyLancet Oncology, The20172,058
4Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1Autophagy20211,430
5Cancer Genetics and Epigenetics: Two Sides of the Same Coin?Cancer Cell2012966
6Can we safely target the WNT pathway?Nature Reviews Drug Discovery2014840
7Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trialsAnnals of Oncology2017654
8HER kinase inhibition in patients with HER2- and HER3-mutant cancersNature2018572
9Genome architectures revealed by tethered chromosome conformation capture and population-based modelingNature Biotechnology2012524
10DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylationMolecular Cancer Therapeutics2009518
11Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signalling and therapeutic targetingBiochemical Journal2011445
12Discovery of common and rare genetic risk variants for colorectal cancerNature Genetics2019377
13Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancersOncotarget2014367
14Environmental epigenetics: prospects for studying epigenetic mediation of exposure–response relationshipsHuman Genetics2012294
15ctDNA guiding adjuvant immunotherapy in urothelial carcinomaNature2021293
16First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Phase II CheckMate 142 StudyJournal of Clinical Oncology2022283
17Circular RNA profile in gliomas revealed by identification tool UROBORUSNucleic Acids Research2016269
18Cell Surface Relocalization of the Endoplasmic Reticulum Chaperone and Unfolded Protein Response Regulator GRP78/BiPJournal of Biological Chemistry2010268
19The critical role of GRP78 in physiologic and pathologic stressCurrent Opinion in Cell Biology2011260
20DNA methylation loss in late-replicating domains is linked to mitotic cell divisionNature Genetics2018258
21Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinomaJournal of Hepatology2020254
22Role of the unfolded protein response, GRP78 and GRP94 in organ homeostasisJournal of Cellular Physiology2015242
23Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient OutcomeJournal of Clinical Oncology2019234
24Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic FactorsGastroenterology2018226
25Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trialLancet Oncology, The2021225
26Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomesEuropean Journal of Cancer2017212
27motifbreakR: an R/Bioconductor package for predicting variant effects at transcription factor binding sitesBioinformatics2015208
28Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 studyThe Lancet Gastroenterology and Hepatology2021205
29FOLFOX4 plus cetuximab treatment and RAS mutations in colorectal cancerEuropean Journal of Cancer2015202
30Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trialLancet Oncology, The2016200
31Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysisNature Communications2020193
32CALGB/SWOG 80405: Phase III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or rectum (MCRC).Journal of Clinical Oncology2014178
33Nivolumab (NIVO) + ipilimumab (IPI) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Results from CheckMate 040.Journal of Clinical Oncology2019178
34Genetic and environmental effects on body mass index from infancy to the onset of adulthood: an individual-based pooled analysis of 45 twin cohorts participating in the COllaborative project of Development of Anthropometrical measures in Twins (CODATwins) studyAmerican Journal of Clinical Nutrition2016175
35Cancer Dormancy: A Model of Early Dissemination and Late Cancer RecurrenceClinical Cancer Research2012173
36Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinomaJournal of Hepatology2020165
37Association BetweenNRASandBRAFMutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary MelanomaJAMA Oncology2015164
38Monoclonal Antibody against Cell Surface GRP78 as a Novel Agent in Suppressing PI3K/AKT Signaling, Tumor Growth, and MetastasisClinical Cancer Research2013154
39Safely targeting cancer stem cells via selective catenin coactivator antagonismCancer Science2014152
40Unique DNA Methylation Patterns Distinguish Noninvasive and Invasive Urothelial Cancers and Establish an Epigenetic Field Defect in Premalignant TissueCancer Research2010148
41Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trialLancet Oncology, The2017148
42Association of Polygenic Risk Scores for Multiple Cancers in a Phenome-wide Study: Results from The Michigan Genomics InitiativeAmerican Journal of Human Genetics2018147
43Oral cedazuridine/decitabine for MDS and CMML: a phase 2 pharmacokinetic/pharmacodynamic randomized crossover studyBlood2020144
44Comparison of Clinicopathologic Features and Survival of Histopathologically Amelanotic and Pigmented MelanomasJAMA Dermatology2014142
45Nonsteroidal Anti-inflammatory Drug Use Reduces Risk of Adenocarcinomas of the Esophagus and Esophagogastric Junction in a Pooled AnalysisGastroenterology2012140
46Characterization and Mechanism of Stress-induced Translocation of 78-Kilodalton Glucose-regulated Protein (GRP78) to the Cell SurfaceJournal of Biological Chemistry2015139
47Genome-wide association study of colorectal cancer identifies six new susceptibility lociNature Communications2015138
48Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trialAnnals of Oncology2019136
49XRCC4:DNA ligase IV can ligate incompatible DNA ends and can ligate across gapsEMBO Journal2007135
50Novel Common Genetic Susceptibility Loci for Colorectal CancerJournal of the National Cancer Institute2019129